The 2024 Career Development Award program is now open for application submissions.

The Career Development Award supports future research leaders who will keep the field of lung cancer research vibrant with new ideas. Research that will be funded in 2024 is expected to have a direct impact on the early detection of lung cancer and/or individualized lung cancer treatment, including through targeted therapy and immunotherapy. This award is open to applicants in the US only.

Award Guidelines

  • Applicants must hold a doctoral degree and be within the first 5 years of their first faculty appointment with any academic institution, including research institutions that are not formally associated with a university, and have completed a postdoctoral training fellowship.
  • This is a mentored award. A mentoring plan is required as part of the application
  • Awards may be for a maximum of $300,000 ($100,000 per year for 3 years)
  • Annual milestones must be met

Note: LUNGevity will grant only one award per institution.

LUNGevity uses a two-step application process:

  1. A letter of intent (LOI), with a brief overview of the proposed project and biographical information
  2. A full application with an extended narrative about the project, as well as supporting information and documentation.(Because the number of awards is limited, only a subset of applicants will be invited to submit a full application after the LOI review is completed.)

Reviewers are drawn from LUNGevity’s Scientific Advisory Board and other lung cancer experts. Awardees have progress and financial reporting obligations during their award term.

A complete description of the award, terms and conditions, and instructions are included in the 2024 Career Development Award RFA. Applications must be submitted via proposalCENTRAL.

2024 Award Timeline

LOIs due:   by February 16, 2024, 11:59 pm EST
Invitation to apply:   No later than March 25, 2024
Applications due:   May 15, 2024, 11:59 pm EDT
Award announcement:   Late summer 2024
Award start date:   November 1, 2024